Short-term Telehealth Follow up After Hospital Discharge for Chronic Obstructive Pulmonary Disease Exacerbation
RHCluster4GR
Renewing Health RCT in Central Greece for the Evaluation of Short-term Telehealth Follow up After Hospital Discharge for COPD Exacerbation
2 other identifiers
interventional
155
1 country
1
Brief Summary
The purpose of this study is to evaluate whether the introduction of a short-term telemonitoring program for chronic obstructive pulmonary disease (COPD) patients discharged from the hospital after disease exacerbation produces benefits in terms of a reduction in hospital readmissions and health related quality of life. In addition the trials evaluate the economical and organisational impact of the services and examine their acceptability by patients and health professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 6, 2011
CompletedFirst Posted
Study publicly available on registry
December 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFebruary 24, 2015
February 1, 2015
2.7 years
December 6, 2011
February 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of hospital readmissions
Number of hospital readmissions after the hospital discharged of the patient after a COPD exacerbation
3 months period
Secondary Outcomes (6)
Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire
3 months - at the entry point of the intervention and the end.
Hospital anxiety and depression scale HADS
3 months - at the entry point of the intervention and the end.
Health status, measured with the St. George's Respiratory Questionnaire SGRQ
3 months - at the entry point of the intervention and the end.
Lung condition as measured by FEV1
1 month after the hospital discharge.
Mortality
3 months period
- +1 more secondary outcomes
Study Arms (2)
Usual care
NO INTERVENTIONPatients in the control group receive usual care and visit the outpatient department at 4 and at 12 weeks after discharge when pulse rate, oxygen saturation and spirometry is performed. In the case of clinical deterioration during the study, the patients contact as usual their general practitioner. Usual care of COPD patients consists of regular visits to the specialist or primary care clinics every time a medication change is made or a medical examination is needed
Telemonitoring
EXPERIMENTALInterventions
Within 24 hours after patient's discharge, the telemedicine equipment is installed at the patient's home and patients are trained in the use of the equipment. Patients are followed by a dedicated telehealth centre. Patients at home are asked to fill out each morning the CAT questionnaire and to record extra use of COPD relief medications. Patients in stable conditions perform telespirometry and teleoximetry at 4 and 12 weeks. When a clinical worsening is detected (increase in CAT score by 5 points or higher on two consecutive days) the patient is contacted and asked to perform ad hoc telespirometry and teleoximetry and to send the data to the telehealth centre.
Eligibility Criteria
You may qualify if:
- Exacerbation of COPD according to the GOLD guidelines
- Age \> 40 years
- Capability to use the devices provided
- Willing to participate
You may not qualify if:
- included in previous COPD monitoring study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Regional Health Authority of Sterea & Thessalylead
- Ministry for Health and Social Solidarity, Greececollaborator
- Municipality of Trikala, Greececollaborator
- e-Trikala S.A.collaborator
- Cities Net SAcollaborator
- Institute of Biomedical Research & Technology, Larissa, Greececollaborator
- Institute of Communications and Computer Systems, Athens, Greececollaborator
- Alexander Technological Educational Institute, Thessaloniki, Greececollaborator
- University of Macedonia, Thessaloniki, Greececollaborator
- University of Thessalycollaborator
Study Sites (1)
Pulmonary Department - Regional University Hospital of Larisa
Larissa, Thessaly, 41110, Greece
Related Publications (1)
Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120-7. doi: 10.1258/jtt.2009.090812. Epub 2010 Mar 2.
PMID: 20197355BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konstantinos Gourgoulianis, MD, PhD
Pulmonary Department - University Hospital of Larisa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of the Pulmonary Department, University Hospital of Larisa
Study Record Dates
First Submitted
December 6, 2011
First Posted
December 9, 2011
Study Start
March 1, 2011
Primary Completion
November 1, 2013
Study Completion
January 1, 2014
Last Updated
February 24, 2015
Record last verified: 2015-02